Cargando…

Age-treatment subgroup analyses in Cochrane intervention reviews: a meta-epidemiological study

BACKGROUND: There is growing interest in evaluating differences in healthcare interventions across routinely collected demographic characteristics. However, individual subgroup analyses in randomized controlled trials are often not prespecified, adjusted for multiple testing, or conducted using the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Patrick, Ioannidis, John P. A., Ross, Joseph S., Dhruva, Sanket S., Luxkaranayagam, Anita T., Vasiliou, Vasilis, Wallach, Joshua D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805640/ https://www.ncbi.nlm.nih.gov/pubmed/31639007 http://dx.doi.org/10.1186/s12916-019-1420-8

Ejemplares similares

Analysis of Postapproval Clinical Trials of Therapeutics Approved by the US Food and Drug Administration Without Clinical Postmarketing Requirements or Commitments
por: Skydel, Joshua J., et al.
Publicado: (2019)

Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: a cross-sectional analysis
por: Wallach, Joshua D., et al.
Publicado: (2019)

Sex based subgroup differences in randomized controlled trials: empirical evidence from Cochrane meta-analyses
por: Wallach, Joshua D, et al.
Publicado: (2016)

A meta-epidemiological study of subgroup analyses in cochrane systematic reviews of atrial fibrillation
por: Paquette, Miney, et al.
Publicado: (2019)

Evaluation of confounding in epidemiologic studies assessing alcohol consumption on the risk of ischemic heart disease
por: Wallach, Joshua D., et al.
Publicado: (2020)

Systematic Differences between Cochrane and Non-Cochrane Meta-Analyses on the Same Topic: A Matched Pair Analysis
por: Useem, Johanna, et al.
Publicado: (2015)

Feasibility of Using Real-world Data to Emulate Postapproval Confirmatory Clinical Trials of Therapeutic Agents Granted US Food and Drug Administration Accelerated Approval
por: Wallach, Joshua D., et al.
Publicado: (2021)

The Impact of Study Size on Meta-analyses: Examination of Underpowered Studies in Cochrane Reviews
por: Turner, Rebecca M., et al.
Publicado: (2013)

Beyond genomics: understanding exposotypes through metabolomics
por: Rattray, Nicholas J. W., et al.
Publicado: (2018)

Influence of pilot and small trials in meta-analyses of behavioral interventions: a meta-epidemiological study
por: Beets, Michael W., et al.
Publicado: (2023)

PEDro or Cochrane to Assess the Quality of Clinical Trials? A Meta-Epidemiological Study
por: Armijo-Olivo, Susan, et al.
Publicado: (2015)

Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study
por: Turner, Kimberly, et al.
Publicado: (2020)

The effectiveness of psychosocial interventions at reducing the frequency of alcohol and drug use in parents: findings of a Cochrane Review and meta‐analyses
por: McGovern, Ruth, et al.
Publicado: (2022)

Environmental risk factors for non-Hodgkin's lymphoma: umbrella review and comparison of meta-analyses of summary and individual participant data
por: Shi, Xiaoting, et al.
Publicado: (2022)

Exploring Treatment by Covariate Interactions Using Subgroup Analysis and Meta-Regression in Cochrane Reviews: A Review of Recent Practice
por: Donegan, Sarah, et al.
Publicado: (2015)

Meta-analysis and The Cochrane Collaboration: 20 years of the Cochrane Statistical Methods Group
por: McKenzie, Joanne E, et al.
Publicado: (2013)

A Re-Analysis of the Cochrane Library Data: The Dangers of Unobserved Heterogeneity in Meta-Analyses
por: Kontopantelis, Evangelos, et al.
Publicado: (2013)

From the Cochrane Library: Interventions for Impetigo
por: Oganesyan, Ani, et al.
Publicado: (2021)

Trends in Within-Class Changes in US Average Wholesale Prices for Brand-Name Medications for Common Conditions From 2015 to 2020
por: Liu, Patrick, et al.
Publicado: (2021)

The evolution of assessing bias in Cochrane systematic reviews of interventions: celebrating methodological contributions of the Cochrane Collaboration
por: Turner, Lucy, et al.
Publicado: (2013)

Interventions for osteoarthritis pain: A systematic review with network meta-analysis of existing Cochrane reviews()
por: Smedslund, Geir, et al.
Publicado: (2022)

From meta‐analysis to Cochrane reviews
por: Ebner, Nicole, et al.
Publicado: (2018)

Evidence supporting FDA approval and CMS national coverage determinations for novel medical products, 2005 through 2016: A cross-sectional study
por: Roginiel, Aliya C., et al.
Publicado: (2018)

Coverage of Novel Therapeutic Agents by Medicare Prescription Drug Plans Following FDA Approval
por: Shaw, Daniel L., et al.
Publicado: (2018)

Assessing bias in osteoarthritis trials included in Cochrane reviews: protocol for a meta-epidemiological study
por: Hansen, Julie B, et al.
Publicado: (2014)

From the Cochrane Library: Interventions for Mycosis Fungoides
por: Kohn Kucharik, Alison, et al.
Publicado: (2022)

From the Cochrane Library: Interventions for Cellulitis and Erysipelas
por: Oganesyan, Ani, et al.
Publicado: (2022)

From the Cochrane Library: Interventions for Acne Scars
por: Cao, Annie L, et al.
Publicado: (2022)

From the Cochrane Library: Interventions for Pityriasis Rosea
por: Méndez, Alejandra, et al.
Publicado: (2023)

False-positive findings in Cochrane meta-analyses with and without application of trial sequential analysis: an empirical review
por: Imberger, Georgina, et al.
Publicado: (2016)

Empirical comparison of univariate and multivariate meta‐analyses in Cochrane Pregnancy and Childbirth reviews with multiple binary outcomes
por: Price, Malcolm J., et al.
Publicado: (2019)

The normality assumption on between-study random effects was questionable in a considerable number of Cochrane meta-analyses
por: Liu, Ziyu, et al.
Publicado: (2023)

Agreement between the Cochrane risk of bias tool and Physiotherapy Evidence Database (PEDro) scale: A meta-epidemiological study of randomized controlled trials of physical therapy interventions
por: Moseley, Anne M., et al.
Publicado: (2019)

Accurate estimation of cardiovascular risk in a non-diabetic adult: detecting and correcting the error in the reported Framingham Risk Score for the Systolic Blood Pressure Intervention Trial population
por: Warner, Frederick, et al.
Publicado: (2018)

Characterization of US Food and Drug Administration Class I Recalls from 2018 to 2022 for Moderate- and High-Risk Medical Devices: A Cross-Sectional Study
por: Mooghali, Maryam, et al.
Publicado: (2023)

Statistical Multiplicity in Systematic Reviews of Anaesthesia Interventions: A Quantification and Comparison between Cochrane and Non-Cochrane Reviews
por: Imberger, Georgina, et al.
Publicado: (2011)

Interventions to Promote Patient Utilization of Cardiac Rehabilitation: Cochrane Systematic Review and Meta-Analysis
por: Santiago de Araújo Pio, Carolina, et al.
Publicado: (2019)

Proportion attributable to contextual effects in general medicine: a meta-epidemiological study based on Cochrane reviews
por: Tsutsumi, Yusuke, et al.
Publicado: (2023)

The lack of statistical power of subgroup analyses in meta-analyses: a cautionary note
por: Cuijpers, Pim, et al.
Publicado: (2021)

The use of older studies in meta-analyses of medical interventions: a survey
por: Patsopoulos, Nikolaos A, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_1idh6smu6kfsimgi2jn86e4kt8